Patents by Inventor Levan Darjania

Levan Darjania has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8853234
    Abstract: The present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: March 9, 2011
    Date of Patent: October 7, 2014
    Assignee: Senhwa Biosciences, Inc.
    Inventors: Johnny Yasuo Nagasawa, Fabrice Pierre, Mustapha Haddach, Michael Schwaebe, Levan Darjania, Jeffrey P. Whitten
  • Publication number: 20110218184
    Abstract: The present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: March 9, 2011
    Publication date: September 8, 2011
    Applicant: CYLENE PHARMACEUTICALS, INC.
    Inventors: Johnny Yasuo NAGASAWA, Fabrice Pierre, Mustapha Haddach, Michael Schwaebe, Levan Darjania, Jeffrey P. Whitten
  • Patent number: 7928100
    Abstract: The present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: April 19, 2011
    Assignee: Cylene Pharmaceuticals, Inc.
    Inventors: Johnny Yasuo Nagasawa, Fabrice Pierre, Mustapha Haddach, Michael Schwaebe, Levan Darjania, Jeffrey P. Whitten
  • Publication number: 20090093455
    Abstract: The present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 9, 2009
    Inventors: Johnny Yasuo NAGASAWA, Fabrice PIERRE, Mustapha HADDACH, Michael SCHWAEBE, Levan DARJANIA, Jeffrey P. WHITTEN
  • Publication number: 20080318938
    Abstract: The invention relates in part to methods for inhibiting proliferation of cancer cells and treating one or more cell proliferative conditions using compounds described herein.
    Type: Application
    Filed: June 20, 2008
    Publication date: December 25, 2008
    Inventors: David M. RYCKMAN, Denis Drygin, Jeffrey P. Whitten, Kenna Anderes, Katy Trent, Levan Darjania, Mustapha Haddach, Sean O'Brien, William G. Rice
  • Publication number: 20080160503
    Abstract: Provided herein are procedures for rapidly determining oral bioavailability of two or more compounds by administering the two or more compounds to an animal, extracting fluid from an eye region of the animal and determining the amount of each of the two or more compounds in the fluid by mass spectrometry. Such procedures can provide cost advantages for determining oral bioavailability as they allow for (i) utilizing relatively small animals, (ii) extracting multiple samples from a single animal, and (iii) analyzing multiple compounds in a single animal, for example.
    Type: Application
    Filed: October 25, 2007
    Publication date: July 3, 2008
    Inventors: Levan DARJANIA, Sean O'Brien